|
regulation of sequestering of calcium ion
|
GO:0051282 |
4 |
0.209
|
|
|
larval development
|
GO:0002164 |
2 |
0.114
|
|
|
sequestering of metal ion
|
GO:0051238 |
3 |
0.096
|
|
|
sequestering of calcium ion
|
GO:0051208 |
3 |
0.092
|
|
|
maintenance of location
|
GO:0051235 |
4 |
0.088
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
2 |
0.068
|
|
|
negative regulation of sequestering of calcium ion
|
GO:0051283 |
4 |
0.063
|
|
|
aging
|
GO:0007568 |
2 |
0.050
|
|
|
response to abiotic stimulus
|
GO:0009628 |
122 |
0.048
|
|
|
aminoglycan metabolic process
|
GO:0006022 |
9 |
0.047
|
|
|
heart development
|
GO:0007507 |
313 |
0.045
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
4 |
0.044
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
2 |
0.043
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
2 |
0.040
|
|
|
nitrogen compound metabolic process
|
GO:0006807 |
319 |
0.038
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
4 |
0.037
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
3 |
0.030
|
|
|
regulation of transmembrane transporter activity
|
GO:0022898 |
2 |
0.029
|
|
|
oxidation reduction process
|
GO:0055114 |
41 |
0.028
|
|
|
carbohydrate derivative metabolic process
|
GO:1901135 |
61 |
0.028
|
|
|
optic placode formation
|
GO:0001743 |
4 |
0.025
|
|
|
specification of symmetry
|
GO:0009799 |
204 |
0.025
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
4 |
0.024
|
|
|
calcium ion homeostasis
|
GO:0055074 |
19 |
0.024
|
|
|
actin filament based movement
|
GO:0030048 |
1 |
0.023
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
29 |
0.023
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
2 |
0.022
|
|
|
adult behavior
|
GO:0030534 |
2 |
0.022
|
|
|
embryonic organ development
|
GO:0048568 |
381 |
0.021
|
|
|
lipid storage
|
GO:0019915 |
1 |
0.021
|
|
|
atp catabolic process
|
GO:0006200 |
4 |
0.021
|
|
|
cation homeostasis
|
GO:0055080 |
33 |
0.020
|
|
|
regulation of transporter activity
|
GO:0032409 |
2 |
0.019
|
|
|
growth
|
GO:0040007 |
174 |
0.019
|
|
|
organic cyclic compound metabolic process
|
GO:1901360 |
301 |
0.019
|
|
|
er nucleus signaling pathway
|
GO:0006984 |
2 |
0.019
|
|
|
single organism metabolic process
|
GO:0044710 |
217 |
0.018
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
4 |
0.018
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
333 |
0.018
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
2 |
0.017
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
4 |
0.017
|
|
|
lipid catabolic process
|
GO:0016042 |
4 |
0.017
|
|
|
negative regulation of heart contraction
|
GO:0045822 |
2 |
0.017
|
|
|
muscle cell differentiation
|
GO:0042692 |
139 |
0.017
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
22 |
0.016
|
|
|
gtp catabolic process
|
GO:0006184 |
2 |
0.016
|
|
|
organonitrogen compound metabolic process
|
GO:1901564 |
74 |
0.016
|
|
|
cellular aromatic compound metabolic process
|
GO:0006725 |
295 |
0.016
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
1 |
0.016
|
|
|
rhodopsin mediated signaling pathway
|
GO:0016056 |
1 |
0.015
|
|
|
lipid oxidation
|
GO:0034440 |
1 |
0.015
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
1 |
0.015
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
15 |
0.014
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
274 |
0.014
|
|
|
eye field cell fate commitment involved in camera type eye formation
|
GO:0060898 |
3 |
0.014
|
|
|
optic placode formation involved in camera type eye formation
|
GO:0046619 |
3 |
0.014
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
1 |
0.013
|
|
|
regulation of nitrogen compound metabolic process
|
GO:0051171 |
251 |
0.013
|
|
|
regulation of nucleobase containing compound metabolic process
|
GO:0019219 |
250 |
0.013
|
|
|
cellular response to external stimulus
|
GO:0071496 |
2 |
0.013
|
|
|
gastrulation
|
GO:0007369 |
208 |
0.013
|
|
|
heterocycle biosynthetic process
|
GO:0018130 |
215 |
0.013
|
|
|
developmental growth
|
GO:0048589 |
166 |
0.013
|
|
|
nucleic acid metabolic process
|
GO:0090304 |
244 |
0.012
|
|
|
cellular biosynthetic process
|
GO:0044249 |
286 |
0.012
|
|
|
gtp metabolic process
|
GO:0046039 |
4 |
0.012
|
|
|
connective tissue development
|
GO:0061448 |
99 |
0.012
|
|
|
positive regulation of transport
|
GO:0051050 |
2 |
0.012
|
|
|
embryonic skeletal joint morphogenesis
|
GO:0060272 |
3 |
0.012
|
|
|
small molecule metabolic process
|
GO:0044281 |
77 |
0.012
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
13 |
0.012
|
|
|
striated muscle cell development
|
GO:0055002 |
108 |
0.012
|
|
|
regulation of microtubule cytoskeleton organization
|
GO:0070507 |
3 |
0.012
|
|
|
ion homeostasis
|
GO:0050801 |
41 |
0.012
|
|
|
response to external stimulus
|
GO:0009605 |
264 |
0.011
|
|
|
regulation of gtpase activity
|
GO:0043087 |
2 |
0.011
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
3 |
0.011
|
|
|
cellular response to radiation
|
GO:0071478 |
4 |
0.011
|
|
|
gene expression
|
GO:0010467 |
252 |
0.011
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
200 |
0.011
|
|
|
cellular cation homeostasis
|
GO:0030003 |
17 |
0.011
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
117 |
0.011
|
|
|
response to unfolded protein
|
GO:0006986 |
2 |
0.011
|
|
|
regulation of biosynthetic process
|
GO:0009889 |
250 |
0.011
|
|
|
organic substance biosynthetic process
|
GO:1901576 |
289 |
0.011
|
|
|
synaptic growth at neuromuscular junction
|
GO:0051124 |
2 |
0.010
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
11 |
0.010
|
|
|
muscle structure development
|
GO:0061061 |
196 |
0.010
|
|
|
absorption of visible light
|
GO:0016038 |
2 |
0.010
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
27 |
0.010
|
|